Suppr超能文献

霉酚酸酯和低剂量泼尼松龙成功治疗系统性硬化症相关心包炎。

Successful Treatment of Systemic Sclerosis-related Pericarditis with Mycophenolate Mofetil and Low-dose Prednisolone.

机构信息

Department of Rheumatology, Aso Iizuka Hospital, Japan.

Department of Medical Education, Kyushu University Graduate School of Medical Sciences, Japan.

出版信息

Intern Med. 2022 Oct 15;61(20):3125-3130. doi: 10.2169/internalmedicine.8844-21. Epub 2022 Mar 12.

Abstract

We herein report a case of systemic sclerosis (SSc)-related pericarditis successfully treated with mycophenolate mofetil (MMF) and low-dose prednisolone (PSL). The patient was a 72-year-old woman with anti-centromere antibody. Her clinical manifestations were Raynaud phenomenon, bilateral pleural effusion, pericardial effusion and skin tightness. Based on the findings of exudative pericardial effusion with the absence of pulmonary arterial hypertension from the results of the cardiac catheter and pericardiocentesis, she was diagnosed with SSc-related pericarditis and treated with PSL10 mg and MMF 1 g per day, leading to the complete resolution of pericarditis. These findings suggested that MMF and low-dose PSL were effective for SSc-related pericarditis.

摘要

我们在此报告一例系统性硬化症(SSc)相关性心包炎,经吗替麦考酚酯(MMF)和低剂量泼尼松龙(PSL)治疗后获得成功。该患者为一名 72 岁女性,抗着丝点抗体阳性。其临床表现为雷诺现象、双侧胸腔积液、心包积液和皮肤紧绷。基于渗出性心包积液的表现,以及心脏导管和心包穿刺术结果中不存在肺动脉高压,诊断为 SSc 相关性心包炎,并接受 PSL 10 mg 和 MMF 1 g 每天的治疗,心包炎完全缓解。这些发现表明 MMF 和低剂量 PSL 对 SSc 相关性心包炎有效。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fba9/9646350/798c2004e003/1349-7235-61-3125-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验